CVX is trading at $2.11, up 2.45% over 24 hours. It sits in the upper portion of its $2.03–$2.14 daily range, indicating a positive near-term session, though the price remains $0.03 below the high.

The hourly short-term moving averages are mildly supportive: the 8, 13, 21, and 55 SMAs are between $2.09 and $2.10, just below the current price, and their supplied changes are positive. In contrast, the 144 SMA is $2.17, 2.82% above the price, so the short-term strength has not cleared the longer hourly average.

Both the 1-hour and 7-day RSI readings are 47. These readings do not show strong momentum in either direction and temper the bullish interpretation of the daily gain and positive short-average readings.

Performance across timeframes is mixed. The 7-day change is -7.99%, a meaningful negative signal, while the 14-day and 30-day changes are positive at 2.64% and 1.67%, respectively; the longer of those two windows therefore shows modest gains, not strong upward momentum.

The 24-hour volume is 4,958,964, and volume relative to market capitalization is 2.52%. Without comparative volume data, those figures establish trading activity but do not confirm whether buying pressure is increasing or unusually strong.

CVX remains about 96.5% below its $60.09 all-time high. That captures the scale of the decline from the historical peak, but the supplied data do not establish a current trend or a price level from which to infer a recovery.

The evidence is balanced rather than decisively bullish or bearish. The daily rebound, price above the short hourly averages, and positive 14- and 30-day returns are countered by the sharp weekly loss, price below the 144 SMA, and neutral RSI readings.

The overall rating is Hold. The primary reason is that near-term price action and shorter-period averages have improved, but the weekly decline and position below the 144 SMA prevent those signals from forming a convincing buy case; neutral RSI readings reinforce the lack of clear directional confirmation.